Shamay and colleagues demonstrated an anti-tumor activity of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugated to an E-selectin binding peptide and loaded with different anti-cancer agents (Shamay et al., 2016b; Shamay et al., 2015). The gene discussed is SELE; the disease is neoplasm.